Home › Companies › Paratek Pharmaceuticals Inc.

Paratek Pharmaceuticals Inc. proxy voting records

How asset managers voted at Paratek Pharmaceuticals Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

• CUSIP issuer number699374
• SEC CIK1178711

Recent shareholder votes

• September 18, 2023 special meeting (2023-2024 proxy season): 2 items in Paratek Pharmaceuticals Inc.'s official results (Form 8-K, filed September 18, 2023); lowest support 60% of votes cast (Non-binding, advisory proposal to approve certain compensation…). Full results and how funds voted.
• July 6, 2023 annual meeting (2023-2024 proxy season): 7 items in Paratek Pharmaceuticals Inc.'s official results (Form 8-K, filed July 11, 2023); lowest support 60% of votes cast (Approval of an Amendment to the Company's Amended and Restated…); Approval of an Amendment to the Company's Amended and Restated… did not pass (60%). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Earlier seasons list this company under the name PARATEK PHARMACEUTICALS INC., as its holders filed it.

Explore Paratek Pharmaceuticals Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.